menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Debulking Surgery and HIPC to Treat Ovarian Cancer

close
Debulking Surgery and HIPC to Treat Ovarian Cancer
Restart
Resume
Choose a format
Media formats available:
Details
Presenters
Comments
  • Overview

    According to the American Cancer Society, over 21,000 new cases of ovarian cancer are diagnosed each year with 15,000 more women dying annually. What are the recent developments in research to improve these odds?  Dr. Robert Bristow, the director of the Kelly Gynecologic Oncology Service and the Johns Hopkins Ovarian Cancer Center of Excellence, joins host Dr. Leslie Lundt to discuss the value of debulking surgeryand hyperthermic intraperitoneal chemotherapy in the treatment of ovarian cancer.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    According to the American Cancer Society, over 21,000 new cases of ovarian cancer are diagnosed each year with 15,000 more women dying annually. What are the recent developments in research to improve these odds?  Dr. Robert Bristow, the director of the Kelly Gynecologic Oncology Service and the Johns Hopkins Ovarian Cancer Center of Excellence, joins host Dr. Leslie Lundt to discuss the value of debulking surgeryand hyperthermic intraperitoneal chemotherapy in the treatment of ovarian cancer.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 4/5/20